An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence

In heterogeneous multiple myeloma (MM) patients treatment decisions are challenging. The hypothesis was that adaptation of treatment intensity (dose reduction [DR] vs. none) according to an objective risk score (revised-myeloma comorbidity index [R-MCI]) rather than physician judgement alone may imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Holler, Maximilian, Ihorst, Gabriele, Reinhardt, Heike, Rösner, Amelie, Braun, Magdalena, Möller, Mandy-Deborah, Dreyling, Esther, Schoeller, Katja, Scheubeck, Sophia, Wäsch, Ralph, Engelhardt, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Plasma Cell Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071131/
https://www.ncbi.nlm.nih.gov/pubmed/36325890
http://dx.doi.org/10.3324/haematol.2022.281489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071131/
https://www.ncbi.nlm.nih.gov/pubmed/36325890
http://dx.doi.org/10.3324/haematol.2022.281489

Ejemplares similares